Pharmacists in French Camp, CA Accepting Medicare

18 Pharmacists found. Showing 1 - 18

Richard Pigao, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6000    Fax: 209-468-7042

Quynh Tu Pham, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W. Hospital Rd., French Camp, CA 95231 Phone: 209-468-6000    Fax: 209-468-7042

Susan C. Lee, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 West Hospital Rd, French Camp, CA 95231 Phone: 209-468-6937    Fax: 209-468-7042

Jered Michael Arquiette Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W. Hospital Rd., French Camp, CA 95231 Phone: 209-468-6000    Fax: 209-468-7042

Dr. Wilson C Leung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6026

Dr. Allen Shek, PHARM.D., BCPS Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 500 West Hospital Rd, San Joaquin General Hospital, Outpatient Pharmacy, French Camp, CA 95231 Phone: 209-482-2670    Fax: 209-461-2409

Sharon J Bae, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 626-808-5085

Ji Hyun Lee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6937    Fax: 209-468-7042

Tiffany Thu Quynh Vu Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-932-3223

Regine Padilla, PHARM. D. Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6600    Fax: 209-468-7042

Gianna Firpo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6000    Fax: 209-468-7042

Vincent Lu Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 916-706-4851

Vincent Banh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6000    Fax: 209-468-7042

Ms. Kyung Rim Kim, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6937    Fax: 209-468-7042

Derek Huang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-932-2959

Dr. Raj Mitan Gandhi, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7751 S Manthey Rd, French Camp, CA 95231 Phone: 408-497-1400    Fax: 209-461-2537

Dr. Julie Mai Dang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7777 South Freedom Drive, French Camp, CA 95231 Phone: 209-946-3400

Andrea Hinton, PHARM. D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 West Hospital Rd, French Camp, CA 95231 Phone: 209-468-6937    Fax: 209-468-7042

News Archive

Boric acid treatment equals best practice for otitis media

Study findings show that a single application of boric acid powder followed by external auditory canal irrigation is as effective as topical ciprofloxacin eardrops for treating active chronic otitis media.

Treating the new hep C generation on their turf

Once a week, Dr. Diana Sylvestre puts her medical expertise to use in a rickety old house frequented by drug users in this small Northern California city.

Cerulean commences dosing in CRLX101-Avastin combination study for metastatic renal cell carcinoma

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.

Crohn's disease drug market driven by TNF-alpha inhibitors Humira and Remicade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in the Crohn's disease drug market, the dominance of TNF-alpha inhibitors such as Abbott/Eisai's Humira and Centocor Ortho Biotech/Schering-Plough/Mitsubishi Tanabe's Remicade will continue over the next decade. Sales of Humira and Remicade, which accounted for more than three-quarters of the market in 2008, will continue to grow through 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

Read more Medical News

› Verified 7 days ago